tag:blogger.com,1999:blog-28450497.post3137462498561742522..comments2008-09-28T21:30:30.871-04:00Adam J. Fein, Ph.D.http://www.blogger.com/profile/12217252282643255442noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-28450497.post-66121499558803050622007-12-11T12:41:00.000-05:002007-12-11T12:41:00.000-05:00Adam, as always a timely and insightful post. If the FDA does have a target on Cardinal it is a reminder of the addage that where there is smoke there is fire.<BR/><BR/>Mark Parrish was a public supporter of strong controls/pedigree types of programs. Wonder what the Cardinal stance is now that he is gone?<BR/><BR/>Thanks, too, for the note on the IntegriChain white paper. Good reading especially in light of this posting! :)<BR/><BR/>All the best to you and yours in the holiday season and all year.<BR/><BR/>A.Anonymousnoreply@blogger.com